Novel Assessment Tools for Osteoporosis Diagnosis and Treatment

被引:15
|
作者
Gong, Bo [1 ]
Mandair, Gurjit S. [1 ]
Wehrli, Felix W. [2 ]
Morris, Michael D. [1 ]
机构
[1] Univ Michigan, Dept Chem, Ann Arbor, MI 48109 USA
[2] Univ Penn, Perelman Sch Med, Dept Radiol, Philadelphia, PA 19104 USA
基金
美国国家卫生研究院;
关键词
Reference point indentation; Fourier transform infrared spectroscopy; Raman spectroscopy; Magnetic resonance imaging; REFERENCE-POINT INDENTATION; BONE TURNOVER MARKERS; FRACTURE RISK-ASSESSMENT; IN-VIVO MEASUREMENT; MARROW FAT-CONTENT; TRABECULAR BONE; QUANTITATIVE ULTRASOUND; CORTICAL BONE; POSTMENOPAUSAL WOMEN; MECHANICAL-PROPERTIES;
D O I
10.1007/s11914-014-0215-2
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
This review describes new technologies for the diagnosis and treatment, including fracture risk prediction, of postmenopausal osteoporosis. Four promising technologies and their potential for clinical translation and basic science studies are discussed. These include reference point indentation (RPI), Fourier transform infrared spectroscopy (FTIR), Raman spectroscopy, and magnetic resonance imaging (MRI). While each modality exploits different physical principles, the commonality is that none of them require use of ionizing radiation. To provide context for the new developments, brief summaries are provided for the current state of biomarker assays, fracture risk assessment (FRAX), and other fracture risk prediction algorithms and quantitative ultrasound (QUS) measurements.
引用
收藏
页码:357 / 365
页数:9
相关论文
共 50 条
  • [21] Risk assessment tools for osteoporosis and fractures in 2022
    Carey, John J.
    Wu, Paulo Chih-Hsing
    Bergin, Diane
    BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY, 2022, 36 (03):
  • [22] Risk assessment tools for osteoporosis: Scope and limits
    Richy, F
    Gourlay, M
    Ross, P
    Sen, SS
    Radican, L
    Deceulaer, F
    Ben Sedrine, W
    Ethgen, O
    Reginster, JY
    OSTEOPOROSIS INTERNATIONAL, 2004, 15 : S11 - S11
  • [23] Risk assessment tools for osteoporosis: Scope and limits
    Richy, F
    Gourlay, M
    Ross, PD
    Sen, SS
    Radican, L
    De Ceulaer, F
    Ben Sedrine, W
    Ethgen, O
    Reginster, JY
    OSTEOPOROSIS INTERNATIONAL, 2003, 14 : S68 - S69
  • [24] Risk assessment tools for osteoporosis: Scope and limits
    Richy, FFY
    Gourlay, M
    Ross, PD
    Sen, SS
    Radican, L
    Ethgen, O
    Reginster, JY
    ARTHRITIS AND RHEUMATISM, 2003, 48 (09): : S215 - S215
  • [25] DXA ERROR INFLUENCE ON THE ASSESSMENT OF A NOVEL ECHOGRAPHIC APPROACH TO OSTEOPOROSIS DIAGNOSIS ON THE SPINE
    Conversano, F.
    Casciaro, S.
    Greco, A.
    Pisani, P.
    Di Paola, M.
    Aventaggiato, M.
    Quarta, E.
    Quarta, L.
    Casilli, O. E.
    Muratore, M.
    OSTEOPOROSIS INTERNATIONAL, 2016, 27 : S493 - S494
  • [26] Diagnosis and treatment of juvenile osteoporosis
    Cimaz, R
    Guez, S
    ARCHIVES DE PEDIATRIE, 2005, 12 (05): : 585 - 593
  • [27] Diagnosis and treatment of pediatric osteoporosis
    Bachrach, Laura K.
    CURRENT OPINION IN ENDOCRINOLOGY DIABETES AND OBESITY, 2014, 21 (06) : 454 - 460
  • [28] Osteoporosis Diagnosis and Medical Treatment
    Warriner, Amy H.
    Saag, Kenneth G.
    ORTHOPEDIC CLINICS OF NORTH AMERICA, 2013, 44 (02) : 125 - +
  • [29] Osteoporosis: Diagnosis, treatment and prevention
    Schulte, HM
    GYNAKOLOGE, 1997, 30 (04): : 352 - 356
  • [30] Osteoporosis: Epidemiology, diagnosis, and treatment
    Iqbal, MM
    SOUTHERN MEDICAL JOURNAL, 2000, 93 (01) : 2 - 18